Aller au contenu

Interactions médicamenteuses

Ado-trastuzumab + Rozanolixizumab

Gravité: Modérée

Ado-trastuzumab and Rozanolixizumab: moderate interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Rozanolixizumab blocks the neonatal Fc receptor, which lowers circulating IgG levels. Ado-trastuzumab emtansine is an IgG1 antibody conjugate, so its exposure and efficacy could theoretically be reduced.

Ce que signifie cette interaction, en termes simples

Ado-trastuzumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ado-trastuzumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.

Niveau de preuve: Low

Pourquoi elle survient

FcRn blockade increases catabolism of IgG-based therapeutics such as trastuzumab emtansine.

Conduite à tenir

Monitor for reduced response to trastuzumab emtansine. Time rozanolixizumab cycles away from treatment where possible, or consider alternatives.

Questions à poser à votre pharmacien

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Ado-trastuzumab et Rozanolixizumab, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Ado-trastuzumab with Rozanolixizumab?

MediHelp rates the interaction as moderate. Ado-trastuzumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which lowers circulating IgG levels. Ado-trastuzumab emtansine is an IgG1 antibody conjugate, so its exposure and efficacy could theoretically be reduced.

How serious is the interaction between Ado-trastuzumab and Rozanolixizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced response to trastuzumab emtansine. Time rozanolixizumab cycles away from treatment where possible, or consider alternatives.

What other medicines interact with Ado-trastuzumab?

MediHelp also lists interactions of Ado-trastuzumab with, for example, Atazanavir, Baricitinib, Ceritinib. The full list is on the Ado-trastuzumab page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter